Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Jacques H, Grosset"'
Autor:
Paul J Converse, Deepak V Almeida, Rokeya Tasneen, Vikram Saini, Sandeep Tyagi, Nicole C Ammerman, Si-Yang Li, Nicole M Anders, Michelle A Rudek, Jacques H Grosset, Eric L Nuermberger
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 8, p e0006728 (2018)
TRIAL REGISTRATION:ClinicalTrials.gov NCT03474198, NCT01659437.
Externí odkaz:
https://doaj.org/article/65826f0602744e5eba53c6c5af40e358
Autor:
Alan Knell, Thomas Berko, Linda Lehman, Tuah Wilson, Sarah Eyangoh, Kingsley Asiedu, Ernest Opoku, Kristien Velding, Edwin Ampadu, Jérôme Robert, Estelle Marion, Bright Osei-Wusu, Annick Chauty, Edward Sarpong, William Faber, Anastasia Nsiah, Ambroise Adeye, Yaw Ampem Amoako, Marie Françoise Ardent, William Thompson, George Amofa, Richard Phillips, Line Ganlonon, John M Macdonald, Elliot Koranteng Tannor, Till F. Omansen, Raymond Omollo, Terry Treadwell, Justice Abotsi, Albert Paintsil, Nanaa Francisca Sarpong, Samuel Osei Mireku, Maxime Kiki, Raoul Saizonou, David Ofori-Adjei, Bernadette Agbavor, Godfred Sarpong, Espoir Sodjinou, Michael Ochieng Otieno, Fred Stephen Sarfo, Paul Saunderson, Aloysius Dzibordzi Loglo, Martial Kindjinou, Justice K. Boakye-Appiah, Beatrice Konadu, Arnaud Yamadjako, Didier Agossadou, Mark Forson, Tjip S. van der Werf, Sally-Ann Ohene, Elizabeth Ofori, Mathias Ndogyele, Ymkje Stienstra, Thaddaeus Egondi, Richard Asamoah-Frimpong, Joseph Ken Adu Poku, Mabel Sarpong-Duah, Joyce Mensah-Bonsu, Felicity Aboagye, Thierry Gateau, Michael Frimpong, Joseph Ofori Nyarko, Mark Wansbrough-Jones, Kabiru Mohamed Abass, Clémence Guegnard, Alexandre Tiendrebeogo, Akpolan, Jacques H. Grosset, Sandor-Adrian Klis, Naomi Adanmado Gersande
Publikováno v:
The Lancet
The Lancet, 2020, 395 (10232), pp.1259-1267. ⟨10.1016/S0140-6736(20)30047-7⟩
The Lancet, Elsevier, 2020, 395 (10232), pp.1259-1267. ⟨10.1016/S0140-6736(20)30047-7⟩
The Lancet, 395(10232), 1259-1267. ELSEVIER SCIENCE INC
The Lancet, 2020, 395 (10232), pp.1259-1267. ⟨10.1016/S0140-6736(20)30047-7⟩
The Lancet, Elsevier, 2020, 395 (10232), pp.1259-1267. ⟨10.1016/S0140-6736(20)30047-7⟩
The Lancet, 395(10232), 1259-1267. ELSEVIER SCIENCE INC
BACKGROUND: Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifam
Autor:
Paul J Converse, Sandeep Tyagi, Yalan Xing, Si-Yang Li, Yoshito Kishi, John Adamson, Eric L Nuermberger, Jacques H Grosset
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 6, p e0003823 (2015)
Treatment of Buruli ulcer, or Mycobacterium ulcerans disease, has shifted from surgical excision and skin grafting to antibiotic therapy usually with 8 weeks of daily rifampin (RIF) and streptomycin (STR). Although the results have been highly favora
Externí odkaz:
https://doaj.org/article/d3a1fd958498456cba69bdab155369a4
Autor:
Paul J Converse, Yalan Xing, Ki Hyun Kim, Sandeep Tyagi, Si-Yang Li, Deepak V Almeida, Eric L Nuermberger, Jacques H Grosset, Yoshito Kishi
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 1, p e2618 (2014)
Diagnosis of the neglected tropical disease, Buruli ulcer, can be made by acid-fast smear microscopy, specimen culture on mycobacterial growth media, polymerase chain reaction (PCR), and/or histopathology. All have drawbacks, including non-specificit
Externí odkaz:
https://doaj.org/article/7dcad3d1367940f4945947cb576dfb05
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 7, Iss 12, p e2598 (2013)
Buruli ulcer (BU) caused by Mycobacterium ulcerans is the world's third most common mycobacterial infection. There is no vaccine against BU and surgery is needed for patients with large ulcers. Although recent experience indicates combination chemoth
Externí odkaz:
https://doaj.org/article/2febf03bf173482dab64c29be2f416e5
Autor:
Deepak V Almeida, Paul J Converse, Si-Yang Li, Sandeep Tyagi, Eric L Nuermberger, Jacques H Grosset
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 7, Iss 2, p e2085 (2013)
Since 2004, treatment of Mycobacterium ulcerans disease, or Buruli ulcer, has shifted from surgery to daily treatment with streptomycin (STR) + rifampin (RIF) for 8 weeks. For shortening treatment duration, we tested the potential of daily rifapentin
Externí odkaz:
https://doaj.org/article/0275bd51ee324fcb91d6e7a9eefd4cab
Autor:
Fred Stephen Sarfo, Paul J Converse, Deepak V Almeida, Jihui Zhang, Clive Robinson, Mark Wansbrough-Jones, Jacques H Grosset
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 7, Iss 3, p e2101 (2013)
Mycobacterium ulcerans infection causes a neglected tropical disease known as Buruli ulcer that is now found in poor rural areas of West Africa in numbers that sometimes exceed those reported for another significant mycobacterial disease, leprosy, ca
Externí odkaz:
https://doaj.org/article/bacc632cdff94fe9ae86bd20401e1b02
Autor:
Mahomed-Yunus S. Moosa, Paul K. Drain, Connie Celum, Afton Dorasamy, Adrienne E Shapiro, Hilary Thulare, Ting Hong, Sabina Govere, Jacques H. Grosset, Carole L. Wallis
Publikováno v:
AIDS. 32:1811-1820
BACKGROUND There is an urgent need for more accurate screening tests for tuberculosis(TB). We assessed the diagnostic accuracy of C-reactive protein (CRP) as a screening test for active TB in HIV-infected ambulatory adults. METHODS CRP levels were me
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 3, p e985 (2011)
Vaccination with Mycobacterium bovis bacille Calmette-Guérin (BCG) is widely used to reduce the risk of childhood tuberculosis and has been reported to have efficacy against two other mycobacterial diseases, leprosy and Buruli ulcer caused by M. ulc
Externí odkaz:
https://doaj.org/article/3e1dae5c13a04fb5a7ad1a9caf8771e1
Autor:
Deepak Almeida, Paul J Converse, Zahoor Ahmad, Kelly E Dooley, Eric L Nuermberger, Jacques H Grosset
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 1, p e933 (2011)
treatment of Mycobacterium ulcerans disease, or Buruli ulcer (BU), has shifted from surgery to treatment with streptomycin(STR)+rifampin(RIF) since 2004 based on studies in a mouse model and clinical trials. We tested two entirely oral regimens for B
Externí odkaz:
https://doaj.org/article/f8f72bb9a98443f1af96a9e5fc639cd8